Concepedia

Author

Sucharita Adluri

Memorial Sloan Kettering Cancer Center

Also Known As

S Adluri, S. Adluri, Sucharita Adluri

24

Publications

2.4K

Citations

14

H-Index

30

Concepts

All Affiliations

Memorial Sloan Kettering Cancer CenterKettering University
SA

About

Sucharita Adluri is an author at Memorial Sloan Kettering Cancer Center specializing in immunology, immunotherapy, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

10

10

1.4K

2

Immunology

10

10

1.4K

3

Pathology

7

7

1K

4

Allergy

3

3

508

5

Cell Biology

3

3

394

Sucharita Adluri

×

14

Publications

2.4K

Citations

14

H-Index

YearCitations

Improved survival in stage III melanoma patients with GM2 antibodies: a randomized trial of adjuvant vaccination with GM2 ganglioside.

Philip O. Livingston, Gabriel Wong, Sucharita Adluri,

Journal of Clinical Oncology

1994

518

Selection of tumor antigens as targets for immune attack using immunohistochemistry: I. Focus on gangliosides

Shengle Zhang, Carlos Cordon‐Cardo, Helen S. Zhang,

International Journal of Cancer

1997

277

Carbohydrate vaccines in cancer: Immunogenicity of a fully synthetic globo H hexasaccharide conjugate in man

Susan F. Slovin, Govindaswami Ragupathi, Sucharita Adluri,

Proceedings of the National Academy of Sciences

1999

253

Phase 1 trial of immunological adjuvant QS-21 with a GM2 ganglioside-keyhole limpet haemocyanin conjugate vaccine in patients with malignant melanoma

Philip O. Livingston, Sucharita Adluri, Friedhelm Helling,

Vaccine

1994

214

GM2-KLH conjugate vaccine: increased immunogenicity in melanoma patients after administration with immunological adjuvant QS-21.

Friedhelm Helling, Shengle Zhang, A Shang,

PubMed

1995

207

Vaccination of high-risk breast cancer patients with mucin-1 (MUC1) keyhole limpet hemocyanin conjugate plus QS-21.

Teresa Gilewski, Sucharita Adluri, Govind Ragupathi,

PubMed

2000

204

Induction of antibodies against GD3 ganglioside in melanoma patients by vaccination with GD3-lactone-KLH conjugate plus immunological adjuvant QS-21

Govindaswami Ragupathi, Michael L. Meyers, Sucharita Adluri,

International Journal of Cancer

2000

124

Immunogenicity of synthetic TF-KLH (keyhole limpet hemocyanin) and sTn-KLH conjugates in colorectal carcinoma patients

Sucharita Adluri, Fiedhelm Helling, Shunichiro Ogata,

Cancer Immunology Immunotherapy

1995

103

Augmenting the immunogenicity of synthetic MUC1 peptide vaccines in mice.

Shengle Zhang, Linda Graeber, Friedhelm Helling,

PubMed

1996

97

Immunization of Mice with a Fully Synthetic Globo H Antigen Results in Antibodies against Human Cancer Cells: A Combined Chemical—Immunological Approach to the Fashioning of an Anticancer Vaccine

Govindaswami Ragupathi, Tae Kyo Park, Shengle Zhang,

Angewandte Chemie International Edition in English

1997

90

Page 1